NS490 · Unit 6

NS490 Unit 6 parenteral nutrition plan example

Medical Nutrition Therapy II Purdue University Global Free custom sample in 24 to 48h

Output of [1,100] mL a day from an enterocutaneous fistula has put the gut of a composite 56-year-old woman on rest, and the NS490 Unit 6 parenteral nutrition plan example builds her intravenous regimen one macronutrient at a time. Its final page matters as much as its first, listing the findings that would reduce, hold or stop the infusion.

What this page holds

For a composite fistula patient, the NS490 Unit 6 parenteral nutrition plan calculates dextrose, amino acids and lipid separately and names in advance the findings that would pause the infusion. Searches like "ns 490 unit 6 assignment example", "ns490 unit 6 sample" and "ns490 unit 6 example" land here.

What a finished NS490 Unit 6 parenteral nutrition plan looks like

A regimen table anchors the plan, with inputs at its head: weight [62] kg against a usual [68], intake minimal for [seven] days, fistula output [1,100] mL, and a PICC confirmed in place. Goals follow, 25 kcal/kg for 1,550 kcal and 1.5 g/kg protein for 93 g, set higher than usual because fistula fluid carries protein away. The table then builds the bag: 93 g amino acids at 4 kcal/g for 372 kcal, 250 mL of 20 percent lipid emulsion for 500 kcal, and 200 g dextrose at 3.4 kcal/g for 680 kcal, totaling 1,552. A glucose infusion rate of 2.24 mg/kg/min is shown and judged safe. Day one starts at 150 g dextrose for refeeding risk, with a stated advancement schedule. The stop criteria page closes the plan.

How a NS490 Unit 6 example is structured

Indication comes first, because parenteral nutrition needs a reason the enteral route cannot serve, and here it is a high-output fistula with bowel rest ordered by the surgeon. Requirements come next, then the macronutrient build, then safety checks, then advancement, then the criteria for changing course. Each macronutrient line shows grams, the energy factor and the kilocalories, so the total can be rebuilt from the parts. Safety checks are arithmetic too: glucose infusion rate, lipid at 0.81 g/kg, and lipid's share of energy at about a third. Fluid is handled in two streams, the PN bag for nutrition and separate replacement for fistula losses, so neither is asked to do the other's job. Advancement follows ASPEN's refeeding consensus, starting at 150 g dextrose with thiamine first. Micronutrients and zinc for fistula losses appear as pharmacy-protocol items with bracketed doses.

An indication stated first

Parenteral nutrition is justified by what the gut cannot do. The plan names the fistula output and the surgeon's bowel rest order, and it says what would allow enteral feeding to take over.

Macronutrients rebuilt from parts

Grams, energy factor and kilocalories appear on every line. Amino acids at 4 kcal/g, lipid emulsion at 2 kcal/mL and dextrose at 3.4 kcal/g sum to 1,552, which a marker can check in a minute.

Rate checks before the bag hangs

A glucose infusion rate of 2.24 mg/kg/min sits well under common ceilings, and lipid at 0.81 g/kg stays within usual limits. Both calculations are shown, not asserted.

Refeeding treated as the first risk

Seven days of minimal intake and an [8.8] percent weight loss put her at risk. Day one holds dextrose at 150 g, thiamine precedes the first bag, and potassium, magnesium and phosphorus are checked every 12 hours at first.

Two streams of fluid

Fistula losses are replaced separately so the nutrition bag is not stretched to cover them. The plan explains why mixing the two makes both harder to adjust.

What would stop the infusion

Triglycerides above 400 mg/dL reduce the lipid, persistent hyperglycemia reduces dextrose, and signs of line infection go to the team. Enteral intake meeting about 60 percent of needs begins the wean.

Where marks go in NS490 Unit 6

A PN rubric tends to ask five things of a plan: a justified indication, correct and complete calculations, safety checks, refeeding management, and monitoring with criteria for change. An indication appears here before any number does, which some submissions never manage. The calculations are reproducible line by line. Safety appears as arithmetic, a glucose infusion rate and a lipid dose per kilogram, rather than as a promise to monitor. Refeeding shapes day one instead of sitting in a paragraph at the end. The stop criteria give thresholds and actions. Weak PN plans commonly lose credit for totals with no macronutrient breakdown, dextrose started at full goal in a patient at refeeding risk, fistula losses folded into the nutrition volume, no route or access stated, and monitoring that lists labs without saying what result changes anything.

Get a NS490 Unit 6 example written to your instructions

Short bowel, obstruction or severe pancreatitis may take the fistula's place in an NS490 Unit 6 case, and some sections provide a PN order template. Include the case, any template supplied, and the rubric. The bag gets built line by line, refeeding shapes day one, and stop criteria carry thresholds. Your first custom sample is free and comes back in 24-48h.

NS490 Unit 6 questions, answered

Which energy value should be used for dextrose in PN?

In parenteral solutions dextrose is hydrated, so the standard value is 3.4 kcal per gram rather than the 4 kcal per gram used for dietary carbohydrate. Using 4 overstates the energy delivered, and markers often check this first. Amino acids are counted at 4 kcal per gram, and lipid emulsions by the manufacturer's value per milliliter.

Should protein energy be counted in the total?

Most current practice counts it, and the example does, so the total reflects everything infused. Some older texts calculate non-protein calories separately and set goals on that basis. Follow the convention your course text uses and state it in the plan, because the two methods give different totals from the same bag.

Does the plan need to mention the type of lipid emulsion?

It helps. Emulsions differ in their oil sources, and the choice can matter for patients on long-term PN or with liver concerns. Naming the type your case or formulary supplies, with one sentence explaining its fit for the patient, shows the lipid was chosen rather than defaulted. Dosing limits should still be cited.